Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.190
-0.050 (-4.03%)
At close: Feb 27, 2026, 4:00 PM EST
1.250
+0.060 (5.04%)
After-hours: Feb 27, 2026, 4:49 PM EST
Artelo Biosciences Employees
Artelo Biosciences had 6 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,575,800
Market Cap
2.53M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 36 |
| Scinai Immunotherapeutics | 31 |
| Dermata Therapeutics | 8 |
| Ensysce Biosciences | 8 |
| Enveric Biosciences | 6 |
| Adial Pharmaceuticals | 5 |
| XORTX Therapeutics | 3 |
| SciSparc | 2 |
ARTL News
- 4 days ago - Artelo Biosciences Provides Business Update Highlighting Clinical Progress and Reports Fiscal 2025 Year-End Financial Results - GlobeNewsWire
- 2 months ago - Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate - GlobeNewsWire
- 3 months ago - Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - Artelo Biosciences Announces Publication of Peer-Reviewed Article on Role of Fatty Acid Binding Proteins in Cancer - GlobeNewsWire
- 4 months ago - Artelo Biosciences Names Veteran Life Sciences Executive Mark Spring, CPA, as Chief Financial Officer - GlobeNewsWire
- 4 months ago - Artelo Biosciences Announces Expanded Clinical Data to be Presented on both ART26.12 and ART27.13 at the 8th Annual Cannabinoid & Endocannabinoid Drug Development Summit - GlobeNewsWire
- 5 months ago - Artelo Biosciences Announces Closing of $2.0 Million Public Offering - GlobeNewsWire
- 5 months ago - Artelo Biosciences Announces Pricing of $2.0 Million Public Offering - GlobeNewsWire